ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,818, issued on Nov. 11, was assigned to NFlection Therapeutics Inc. (Boston).
"Thienyl-aniline compounds for treatment of dermal disorders" was invented by John Kincaid (Boston) and Matthew Duncton (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating diseases or disorders in a subject where the subject is in need of an inhibitor of MEK where the compound is according to formula (I): where R1, R2, R2a, R3, and R3a are as described herein."
The patent was filed on No...